HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Parliament Passes Updated Cosmetics Directive For All 27 European States

This article was originally published in The Rose Sheet

Executive Summary

The European Parliament has modernized cosmetics oversight by replacing the national laws of its 27 member-countries with a single regulation

You may also be interested in...



EC's Delayed Nano Inventory Reflects Notification Errors, Definitional Challenges

A European Commission official says the long-awaited cosmetic nanomaterials inventory has been delayed due to notification inaccuracies, likely reflecting challenges associated with the "nanomaterial" definition enshrined in regulations. Nevertheless, the EC says it is nearing completion, and trade group Cosmetics Europe believes the catalogue could release this summer.

EU Ushers In New Cosmetics Regs; Experts Offer Perspective

The EU’s new cosmetics regulation focuses on ensuring product safety and brings blanket regulatory uniformity to member states. It also could give rise to conflicts of interest within the supply chain and other challenges, experts say.

In Brief

The EU’s Cosmetics Regulation, which replaces the 1976 Cosmetics Directive, is now in effect, ensuring that consumers are “better protected and have clearer information about the cosmetics they buy,” the European Commission says. More news in brief.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016056

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel